Intravenous enterostatin does not affect single meal food intake in man.

@article{Rssner1995IntravenousED,
  title={Intravenous enterostatin does not affect single meal food intake in man.},
  author={Stephan R{\"o}ssner and Britta S Barkeling and Charlotte Erlanson-Albertsson and Per E. Larsson and E. W{\aa}hlin-Boll},
  journal={Appetite},
  year={1995},
  volume={24 1},
  pages={37-42}
}
Enterostatin, a pentapeptide released with colipase from pancreatic procolipase in man, affects eating behaviour in animals. We report the first phase II study of intravenous (i.v.) enterostatin (D3800) in obese but otherwise healthy men. Eighteen men (mean age 37 years, mean body mass index 34.9 kg/m2) completed a double-blind, randomized, crossover placebo controlled trial. After in initial session, each man received i.v. 4 mg D3800, 16 mg D3800 or placebo in random order over three sessions… CONTINUE READING